Clinical Trial Update: A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the virologic efficacy and safety of VH3810109 in combination with cabotegravir compared with standard of care in adults with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VH3810109 (VH3810109)
• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 2 | Status: ACTIVE_NOT_RECRUITING